The biotechnology sector is seeing a surge of smart solutions that incorporate information communication technology (ICT) advances to enable biomedical devices to deliver higher precision. This has become a key development trend for the healthcare industry. Having long dedicated to ICT and biotech developments, Taiwan is among the world's leading nations for innovation and technology. If Taiwan can combine its strength in ICT and biotech, it will be able to create unique industry advantages. In view of this, the Taiwan government has been actively driving smart biotech developments by conjoining efforts from the industry, government, academic and research sectors. The result of their efforts is now demonstrated by a firm based in the Southern Taiwan Science Park (STSP).

Fully committed to smart biotech developments in recent years, STSP has fostered a cluster of 78 firms, and its close collaborations with research hospitals has allowed the cluster to build up robust R&D capability. In the wake of the COVID-19 pandemic, biotech plays a critical role safeguarding the world against the coronavirus. STSP's biotech strength thus takes center stage again. For example, Visionatics, an STSP tenant devoted to the development of smart image processing technologies, has created VIVA Vision, a machine vision software library delivering performance on par with the work of leading international developers. Based on its achievements in smart image processing, Visionatics further developed In Vitro Diagnostics (IVD), which provides strong support helping small and medium businesses with limited resources expand into the smart biotechnology sector.

Please refer to the link.